Breast Cancer with Brain Metastases: the Role and Treatment Consideration of Radiotherapy

Similar documents
Metastatic Bone Adenocarcinoma with Positive TTF-1 Tumor Stain with a Lung Mass: the Role and Treatment Consideration of RT

Case Number: RT (M) Potential Audiences: Intent Doctor, Oncology Special Nurse, Resident Doctor

Huge Right SCF Mass in a Case of Double Cancer (Buccal Cancer and Hepatoma): the Role and Treatment Consideration of RT

Case Number: RT (M) Potential Audiences: Intent Doctor, Oncology Special Nurse, Resident Doctor

Malignant Peripheral Nerve Sheath Tumor post Wide Excision with Multiple Lung Metastases: the Role and Treatment Consideration of RT

Case Number: RT (M) Potential Audiences: Intent Doctor, Oncology Special Nurse, Resident Doctor

How to Manage Esophagus Cancer Patients with ct3n0m0, stage III Disease?

Lung Cancer with Mediastinum Invasion: the Consideration of Radiotherapy

How to Manage a Case of Stage-I Oropharyngeal Cancer with Very Close Cutting End Post-Operatively?

1/25/13 Right partial nephrectomy followed by completion right radical nephrectomy.

Case Scenario 1. The patient agreed to a CT guided biopsy of the left upper lobe mass. This was performed and confirmed non-small cell carcinoma.

Case Scenario 1. 2/15/2011 The patient received IMRT 45 Gy at 1.8 Gy per fraction for 25 fractions.

Prostate Case Scenario 1

Slide 1. Slide 2. Slide 3. Investigation and management of lung cancer Robert Rintoul. Epidemiology. Risk factors/aetiology

Thoracic Recurrences. Soft tissue recurrence

Diagnosis & Interventions

Lung. 10/24/13 Chest X-ray: 2.9 cm mass like density in the inferior lingular segment worrisome for neoplasm. Malignancy cannot be excluded.

Newton Wellesley Hospital 2013

Case Scenario 1. Pathology report Specimen from mediastinoscopy Final Diagnosis : Metastatic small cell carcinoma with residual lymphatic tissue

Outline. WBRT field. Brain Metastases. Whole Brain RT Prophylactic WBRT Stereotactic radiosurgery (SRS) 1 fraction Stereotactic frame

Case Scenario 1 History and Physical 3/15/13 Imaging Pathology

Palliative radiotherapy near the end of life for brain metastases from lung cancer: a populationbased

Department of Endocrine & Breast Surgery Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow, India

SEER Summary Stage Still Here!

Pancreas Case Scenario #1

North of Scotland Cancer Network Clinical Management Guideline for Non Small Cell Lung Cancer

San Antonio Breast Cancer Symposium 2010 Highlights Radiotherapy

Index. Surg Oncol Clin N Am 16 (2007) Note: Page numbers of article titles are in boldface type.

Lung Cancer Imaging. Terence Z. Wong, MD,PhD. Department of Radiology Duke University Medical Center Durham, NC 9/9/09

Maria João Cardoso, MD, PhD

Case Scenario #1 Larynx

Targeted Therapies in the Management of Non-Small Cell Lung Cancer. A Multi-Disciplinary Approach

Case Scenario 1 Worksheet. Primary Site C44.4 Morphology 8743/3 Laterality 0 Stage/ Prognostic Factors

11/21/13 CEA: 1.7 WNL

Molly Boyd, MD Glenn Mills, MD Syed Jafri, MD 1/1/2010

Treatment of Multiple Lung Tumors

Ashley Pyfferoen, MS, CMD. Gundersen Health Systems La Crosse, WI

RADIOTHERAPY IN BREAST CANCER :

Guideline for the Management of Vulval Cancer

Boot Camp Case Scenarios

PRINCESS MARGARET CANCER CENTRE CLINICAL PRACTICE GUIDELINES

Lara Kujtan, MD; Abdulraheem Qasem, MD

Selecting the Optimal Treatment for Brain Metastases

Gamma Knife Radiosurgery A tool for treating intracranial conditions. CNSA Annual Congress 2016 Radiation Oncology Pre-congress Workshop

Managing Bone Pain in Metastatic Disease. Rachel Schacht PA-C Medical Oncology and Hematology Associates Presented on 11/2/2018

Case Scenario 1: This case has been slightly modified from the case presented during the live session to add clarity.

W3C Life Sciences: Clinical Observations Interoperability: EMR + Clinical Trials Use-case for EMR + Clinical Trials Interoperability

Hong Kong Hospital Authority Convention 2018

Seventh Edition Staging 2017 Breast

Case Scenario 1. Discharge Summary

Goals and Objectives: Head and Neck Cancer Service Department of Radiation Oncology

Cancer of Unknown Primary (CUP) Protocol

When do you need PET/CT or MRI in early breast cancer?

National Optimal Lung Cancer Pathway

MANAGEMENT OF COLORECTAL METASTASES. Robert Warren, MD. The Postgraduate Course in General Surgery March 22, /22/2011

Treatment of Locally Advanced Rectal Cancer: Current Concepts

Retrospective analysis to determine the use of tissue genomic analysis to predict the risk of recurrence in early stage invasive breast cancer.

Case Scenario year-old white male presented to personal physician with dyspepsia with reflux.

Proposed All Wales Vulval Cancer Guidelines. Dr Amanda Tristram

ADJUVANT CHEMOTHERAPY...

Rapidly Progressive Skin Metastasis in EGFR Wild and ALK Fusion Negative Adenocarcinoma Lung: An Unusual Presentation

Combined chemotherapy and Radiotherapy for Patients with Breast Cancer and Extensive Nodal Involvement.

New Visions in PET: Surgical Decision Making and PET/CT

B REAST STAGING FORM. PATHOLOGIC Extent of disease through completion of definitive surgery. CLINICAL Extent of disease before any treatment

B REAST STAGING FORM. PATHOLOGIC Extent of disease through completion of definitive surgery. CLINICAL Extent of disease before any treatment

The Role of Radiation Therapy in the Treatment of Brain Metastases. Matthew Cavey, M.D.

Radiotherapy Physics and Equipment

Epidemiology, aetiology and the patient pathway in oesophageal and pancreatic cancers

Case Scenario 1. 4/19/13 Bone Scan: No scintigraphic findings to suggest skeletal metastases.

Chirurgie beim oligo-metastatischen NSCLC

PET/CT in lung cancer

ES-SCLC Joint Case Conference. Anthony Paravati Adam Yock

PET/CT in breast cancer staging

Breast Cancer. Most common cancer among women in the US. 2nd leading cause of death in women. Mortality rates though have declined

Case Scenario 1: Thyroid

Single Technology Appraisal (STA)

Breast Cancer. Saima Saeed MD

ACOS Inquiry and Response Selected Inquires CS Tumor Size/Extension Evaluation, CS Lymph Nodes Evaluation, CS Metastasis at Diagnosis Evaluation *

STAGE CATEGORY DEFINITIONS

The given bone scan and the PSA reports (as mentioned in the structured summary), suggests metastatic prostate cancer which has spread to the bones.

Multidisciplinary management of retroperitoneal sarcomas

MUSCLE - INVASIVE AND METASTATIC BLADDER CANCER

Case Scenario. 7/13/12 Anterior floor of mouth biopsy: Infiltrating squamous cell carcinoma, not completely excised.

Radiotherapy symptoms control in bone mets. Francesco Cellini GemelliART. Ernesto Maranzano,MD. Session 5: Symptoms management

Case Scenario 1 Discharge Summary Pathology Report Final Diagnosis: Oncology Consult

PRINCESS MARGARET CANCER CENTRE CLINICAL PRACTICE GUIDELINES GYNECOLOGIC CANCER CERVIX

Re-audit of Radiotherapy Waiting Times 2005

Indeterminate Pulmonary Nodules in Patients with Colorectal Cancer

Case Scenario 1. Pathology: Specimen type: Incisional biopsy of the glottis Histology: Moderately differentiated squamous cell carcinoma

Radiology Pathology Conference

RADIOTHERAPY DEPARTMENT

One stop shop. Natalie D. Klass, MD

Acute and late adverse effects of breast cancer radiation: Two hypo-fractionation protocols

Upper GI Malignancies Imaging Guidelines for the Management of Gastric, Oesophageal & Pancreatic Cancers 2012

ARROCase: Locally Advanced Endometrial Cancer

A Step Forward in Cancer Patient Care:

Intended for use by Clinicians and Health Care Providers involved in the Management or Referral of adult patients with pancreatic

North of Scotland Cancer Network Clinical Management Guideline for Endometrial Cancer

Tania Kaprealian, M.D. Assistant Professor UCLA Department of Radiation Oncology August 22, 2015

Transcription:

Breast Cancer with Brain Metastases: the Role and Treatment Consideration of Radiotherapy Case Number: RT2009-127(M) Potential Audiences: Intent Doctor, Oncology Special Nurse, Resident Doctor Purpose: to present a case with breast cancer with brain metastases; to discuss the role and treatment consideration of radiotherapy Scenario: You are radiotherapy (RT) Intent Doctor/Special Nurse/Resident Doctor, and you are assigned to evaluate the following patient before visiting of your RT attending physician. Please review the following description carefully; your RT attending physician will visit this patient later and discuss with you after your review. Case Presentation: This 49 year-old female patient, 李 OO, was referred to us for radiotherapy assessment of breast cancer (very local advanced stage at first) post neo-adjuvant chemotherapy (TP x1 in 2008/04) then MRM (2008/06, LMC), ypt3n2m0, stage IIIA, (2008/06, AJCC2006), then skin nodules and brain metastases were noted, rt0nxm1, r-stage IV. Hence, we need your help for whole brain radiotherapy of multiple brain metastases. Thanks a lot. S: 1. She is a case of histologically proven left breast cancer post neo-adjuvant chemotherapy and MRM at other hospital. Post-MRM radiotherapy for left chest wall and left SCF was done. RT dose fractionation was unknown. 2. In 2009/04, multiple brain mets with significant peri-focal edema were found by brain CT evidence. 3. On 2009/05/05, you visited this patient in the ward. Histories: NDKA; no major disease history. Review of systems: dizziness for days; right limbs weakness with ataxia also noted; memory partial impairment also noted. O: 1. General Condition: ECOG, 2-3; sitting on a wheelchair; speech, OK 2. PEs: erythematous skin lesions over the chest wall and forehead; LNs over the necks and the right axillary region; weakness over the right limbs; no edema on the limbs. 3. ***Pathology in 2008/06, other hospital, MRM (formal report not seen): infiltrating duct carcinoma. 4. Images: (1). Brain CT in 2009/04: multiple low-density regions over the bilateral hemisphere of the brain; a noted brain nodule over the left occipital lobe of the brain, suspect multiple brain metastases with significant peri-focal edema (2). CXR in 2009/05: right diaphragm elevation 5. Others: no available data of tumor makers

Key Image(s): Fig. 1. Fig. 2. Fig. 3.

Questions & Discussions: (Please answer the following questions commented from your RT attending physician.) Q1: What are your findings/interpretations for the above key image(s)? Q2: What is your clinical cancer stage, according to the AJCC 2006, for this case? Q3: What is your pathologic cancer stage, according to the AJCC 2006, for this case? Q4: What are your Oncology Diagnosis / Assessments for this case? Q5: What is your Oncology Plan for this case? Q6: What is your Radiotherapy Plan for this case? (Please reply with the following form: Indication/Contraindication, Goal, Target & Volume, Technique, and Dose & Fractionation.)

Questions & Discussions: (with potential answers) (Please answer the following questions commented from your RT attending physician.) Q1: What are your findings/interpretations for the above key image(s)? A1: As described in the last attached page. Q2: What is your clinical cancer stage, according to the AJCC 2006, for this case? A2: initial ct4nxmx, stage III at least (2008/04, other hospital); rct4b(skin)n3c(left SCF)M1(brain), rc-stage IV (2009/04, AJCC 2006) Q3: What is your pathologic cancer stage, according to the AJCC 2006, for this case? A3: ypt3n2m0, yp-stage IIIA (2008/06, AJCC 2006) Q4: What are your Oncology Diagnosis / Assessments for this case? A4: Oncology Diagnosis: Infiltrating duct carcinoma, Gx, of the left breast, initial ct4nxmx, stage III at least (2008/04, other hospital), post neo-adjuvant chemotherapy (TP x1 in 2008/04) then MRM (2008/06, other hospital), ypt3n2m0, yp-stage IIIA (2008/06, AJCC 2006), then chemotherapy and RT (dose fractionation unknown), with skin nodules and brain metastases, rct4b(skin)n3c(left SCF)M1(brain), rc-stage IV (2009/04, AJCC 2006) Q5: What is your Oncology Plan for this case? A5: Suggest: (1). Arrange Brain MRI if you agreed; (2). Keep chemotherapy; add palliative RT; (3). Arrange chest CT to further assess the lung mass that was revealed by CXR. Q6: What is your Radiotherapy Plan for this case? (Please reply with the following form: Indication/Contraindication, Goal, Target & Volume, Technique, and Dose & Fractionation.) A6: RT Plan may be designed as the following one: (1). Indication: Multiple brain metastases; metastatic skin nodules; may consider RT to the right lung hilar mass (2). Goal: palliative to potential prolong survival; symptoms alleviation and function preservation (3). Target & Volume: whole brain irradiation (4). Technique: 2DRT (5). Dose & Fractionation: 3060 cgy in 17 fractions with or without boost up to 5040-5940 cgy in 28-33 fractions, depending on patient s symptoms. Further Readings & References: NCCN 2009 & Perez 2008 & AJCC 2006 Radiation Oncologist Hon-Yi Lin 2009/05/06

Key Image(s): (with marked) Fig. 1. Fig. 1. A nodule with size about 1.5 cm over the left occipital lobe (as the short white arrow) with associated peri-focal edema of the adjacent brain tissue, c/w brain metastasis (as the long white arrow). Fig. 2. Fig. 2. Bilateral parietal lobes show significant peri-focal edema (as the white arrows). Fig. 3. Fig. 3. The CXR showed a right hilar mass (as the long white arrow) with associated RLL atelectasis (as the short white arrow); the portal-a in place was noted (as the white arrow head).